Dexcom stock price

Dexcom stock price DEFAULT

Invest in DexCom Inc on Stash

Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). ©2021 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

Sours: https://www.stash.com/investments/stocks/dexcom-inc-dxcm/

DexComNasdaqGS:DXCM Stock Report

DexCom Competitors

Price History & Performance

Historical stock prices
Current Share PriceUS$548.05
52 Week HighUS$305.63
52 Week LowUS$579.00
Beta0.74
1 Month Change1.41%
3 Month Change24.16%
1 Year Change39.10%
3 Year Change313.19%
5 Year Change568.35%
Change since IPO4,568.23%

Recent News & Updates

Oct 08

DexCom's Price: With The New G7 System And Partnerships, It May Spike Up

Headquartered in San Diego, California, DXCM is a medical device company offering FDA-approved glucose monitoring technologies. In my opinion, the company’s technology absolutely changes the health of those who can’t control their glucose level on their own. I would say that DXCM saves lives every day. In my view, investors are giving the company a significant amount of cash, so that the management can invest in marketing to enhance sales growth. Negotiations with national health systems and private third-party payors may take some time. But, once the management signs a few agreements, investors will most likely expect recurrent revenue. My figures include 34%-11% sales growth from 2021 to 2031, CFO/Sales of approximately 13%-27%, and capex/sales close to 9%. In sum, I expect that the free cash flow will grow from $92 million in 2021 to more than $4.27 billion in 2031.

Sep 30
Here's Why We Think DexCom (NASDAQ:DXCM) Is Well Worth Watching

Here's Why We Think DexCom (NASDAQ:DXCM) Is Well Worth Watching

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Shareholder Returns

DXCMUS Medical EquipmentUS Market
7D1.1%-1.3%0.7%
1Y39.1%19.2%24.8%

Return vs Industry: DXCM exceeded the US Medical Equipment industry which returned 18.9% over the past year.

Return vs Market: DXCM exceeded the US Market which returned 23.2% over the past year.

Price Volatility

DXCM volatility
DXCM Beta0.74
Industry Beta0.88
Market Beta1

Stable Share Price: DXCM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: DXCM's weekly volatility (5%) has been stable over the past year.

About the Company

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system.

DexCom Fundamentals Summary

DXCM fundamental statistics
Market CapUS$53.02b
Earnings (TTM)US$530.60m
Revenue (TTM)US$2.17b

Earnings & Revenue

DXCM income statement (TTM)
RevenueUS$2.17b
Cost of RevenueUS$669.40m
Gross ProfitUS$1.50b
ExpensesUS$969.90m
EarningsUS$530.60m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Oct 28, 2021

Earnings per share (EPS)5.48
Gross Margin69.15%
Net Profit Margin24.45%
Debt/Equity Ratio85.6%

How did DXCM perform over the long term?

See historical performance and comparison

Valuation

Is DexCom undervalued compared to its fair value and its price relative to the market?

99.93x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: DXCM ($548.05) is trading above our estimate of fair value ($313.43)

Significantly Below Fair Value: DXCM is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: DXCM is poor value based on its PE Ratio (99.9x) compared to the US Medical Equipment industry average (46.8x).

PE vs Market: DXCM is poor value based on its PE Ratio (99.9x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: DXCM is poor value based on its PEG Ratio (4.1x)


Price to Book Ratio

PB vs Industry: DXCM is overvalued based on its PB Ratio (26.5x) compared to the US Medical Equipment industry average (4.4x).


Future Growth

How is DexCom forecast to perform in the next 1 to 3 years based on estimates from 22 analysts?

24.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: DXCM's forecast earnings growth (24.2% per year) is above the savings rate (2%).

Earnings vs Market: DXCM's earnings (24.2% per year) are forecast to grow faster than the US market (15.1% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: DXCM's revenue (19.1% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: DXCM's revenue (19.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DXCM's Return on Equity is forecast to be low in 3 years time (16.1%).


Past Performance

How has DexCom performed over the past 5 years?

65.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: DXCM has a high level of non-cash earnings.

Growing Profit Margin: DXCM's current net profit margins (24.5%) are higher than last year (11.9%).


Past Earnings Growth Analysis

Earnings Trend: DXCM has become profitable over the past 5 years, growing earnings by 65.8% per year.

Accelerating Growth: DXCM's earnings growth over the past year (159.2%) exceeds its 5-year average (65.8% per year).

Earnings vs Industry: DXCM earnings growth over the past year (159.2%) exceeded the Medical Equipment industry 40.5%.


Return on Equity

High ROE: DXCM's Return on Equity (26.6%) is considered high.


Financial Health

How is DexCom's financial position?


Financial Position Analysis

Short Term Liabilities: DXCM's short term assets ($3.5B) exceed its short term liabilities ($600.7M).

Long Term Liabilities: DXCM's short term assets ($3.5B) exceed its long term liabilities ($1.9B).


Debt to Equity History and Analysis

Debt Level: DXCM's debt to equity ratio (85.6%) is considered high.

Reducing Debt: DXCM's debt to equity ratio has increased from 0% to 85.6% over the past 5 years.

Debt Coverage: DXCM's debt is well covered by operating cash flow (23.9%).

Interest Coverage: DXCM's interest payments on its debt are well covered by EBIT (3.7x coverage).


Balance Sheet


Dividend

What is DexCom current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate DXCM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DXCM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DXCM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DXCM's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DXCM's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

US$13,804,156

Compensation

Mr. Kevin Ronald Sayer has been Executive Chairman of DexCom, Inc. since July 30, 2018. Mr. Sayer has been the Chief Executive Officer of DexCom, Inc. since January 5, 2015 and as its President since June...


CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD13.80M) is about average for companies of similar size in the US market ($USD11.27M).

Compensation vs Earnings: Kevin's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: DXCM's management team is considered experienced (3 years average tenure).


Board Members

Experienced Board: DXCM's board of directors are considered experienced (5.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: DXCM insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

DexCom, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: DexCom, Inc.
  • Ticker: DXCM
  • Exchange: NasdaqGS
  • Founded: 1999
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$53.023b
  • Shares outstanding: 96.75m
  • Website: https://www.dexcom.com

Number of Employees


Location

  • DexCom, Inc.
  • 6340 Sequence Drive
  • San Diego
  • California
  • 92121
  • United States

Listings


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2021/10/13 22:31
End of Day Share Price2021/10/13 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Sours: https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom
  1. Lendup personal loan
  2. 1999 ford f250 weight
  3. Warcraft 1 box art

More stories below advertisement

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Sours: https://www.theglobeandmail.com/investing/markets/stocks/DXCM-Q/
Cathie Wood: This Stock Will 50X And Outperform Tesla Stock (BIG INVESTMENT OPPORTUNITY)

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Source: FactSet

Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet

Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones

Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones

ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones

Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Currencies: Currency quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet

Data are provided 'as is' for informational purposes only and are not intended for trading purposes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)

Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media

Sours: https://www.wsj.com/market-data/quotes/DXCM

Stock price dexcom

DexCom Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Source: FactSet

Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet

Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones

Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones

ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones

Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Currencies: Currency quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet

Data are provided 'as is' for informational purposes only and are not intended for trading purposes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)

Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media

Sours: https://www.barrons.com/market-data/stocks/dxcm
DexCom, Inc. (DXCM) Stock - Great Fundamentals - 30% Undervalued

The Quote Overview page gives you a snapshot view for a specific symbol. Real-time prices are provided by Cboe BZX Exchange on individual U.S. equities quote pages. During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). Volume always reflects consolidated markets. If the symbol has pre-market or post-market trades, that information will also be reflected along with the last (closing) price from the symbol's exchange. Real-time prices are available during market hours (9:30 AM to 4:00 PM EST).

Note: The Cboe BZX Exchange currently accounts for approximately 11-12% of all U.S. equity trading each day. As a result, the real-time prices displayed may have minor discrepancies when comparing the information with other sites offering real-time data, or with brokerage firms. If you require comprehensive real-time bids/asks/quotes, we offer a no-risk trial to one of our real-time products.

Summary Quoteboard

The Summary Quoteboard displays snapshot quote data. When available, Bid and Ask information from the Cboe BZX Exchange is updated as new data is received. Volume is also updated but is the delayed consolidated Volume from the symbol's exchange. Quoteboard data fields include:

  • Day High / Low: The highest and lowest trade price for the current trading session.
  • Open: The opening price for the current trading session is plotted on the day's High/Low histogram.
  • Previous Close: The closing price from the previous trading session.
  • Bid: The last bid price and bid size.
  • Ask: The last ask price and ask size.
  • Volume: The total number of shares or contracts traded in the current trading session.
  • Average Volume: The average number of shares traded over the last 20 days.
  • Weighted Alpha: A measure of how much a stock or commodity has risen or fallen over a one-year period. Barchart takes this Alpha and weights this, assigning more weight to recent activity, and less (0.5 factor) to activity at the beginning of the period. Thus, Weighted Alpha is a measure of one-year growth with an emphasis on the most recent price activity.

Chart Snapshot

A thumbnail of a daily chart is provided, with a link to open and customize a full-sized chart.

Barchart Technical Opinion

The Barchart Technical Opinion widget shows you today's overally Barchart Opinion with general information on how to interpret the short and longer term signals. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy.

A symbol will be given one of the following overall ratings:

  • Strong Buy (greater than "66% Buy")
  • Buy (greater than or equal to "33% Buy" and less than or equal to "66% Buy")
  • Weak Buy ("0% Buy" through "33% Buy")
  • Hold
  • Strong Sell (greater than "66% Sell")
  • Sell (greater than or equal to "33% Sell" and less than or equal to "66% Sell")
  • Weak Sell ("0% Sell" through "33% Sell")

The current reading of the 14-Day Stochastic indicator is also factored into the interpretation. The following information will appear when the following conditions are met:

  • If the 14-Day Stochastic %K is greater than 90 and the Overall Opinion is a Buy, the following displays: "The market is in highly overbought territory. Beware of a trend reversal."
  • If the 14-Day Stochastic %K is greater than 80 and the Overall Opinion is a Buy, the following displays: "The market is approaching overbought territory. Be watchful of a trend reversal."
  • If the 14-Day Stochastic %K is less than 10 and the Overall Opinion is a Sell, the following displays: "The market is in highly oversold territory. Beware of a trend reversal."
  • If the 14-Day Stochastic %K is less than 20 and the Overall Opinion is a Sell, the following displays: "The market is approaching oversold territory. Be watchful of a trend reversal."
Business Summary

Provides a general description of the business conducted by this company.

Price Performance

This section shows the Highs and Lows over the past 1, 3 and 12-Month periods. Click the "See More" link to see the full Performance Report page with expanded historical information.

Fundamentals
  • For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more.
  • Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million.
  • Shares Outstanding: Common shares outstanding as reported by the company on the 10-Q or 10-K.
  • Annual Sales: The annual sales, expressed in millions of dollars.
  • Annual Income: The annual net income, expressed in millions of dollars.
  • 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500.
  • Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.
  • Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share.
  • Price/Book: A financial ratio used to compare a company's current market price to its book value.
  • Price/Earnings: Latest closing price divided by the earnings-per-share based on the trailing 12 months. Companies with negative earnings receive an "NE."
  • Earnings Per Share: The trailing 12 months EPS from total operations is the bottom line income after all expenses, divided by the weighted average number of common shares outstanding. For example, if a company has $10 million in net income and 10 million in outstanding shares, then its EPS is $1.
  • Most Recent Earnings: The amount of latest Earnings Per Share (EPS) paid out to shareholders and the date paid. Most Recent Earnings figures are based on Non-GAAP income from continuing operations.
  • Next Earnings Date: The next reported earnings date.
  • Annual Dividend & Yield: The indicated annual dividend rate and yield, calculated from the latest dividend. The dividend rate is the portion of a company's profit paid to shareholders, quoted as the dollar amount each share receives (dividends per share). Yield is the amount of dividends paid per share, divided by the closing price.
  • Most Recent Dividend: The most recent dividend paid and the most recent dividend date.
  • Sectors: Links to the Industry Groups and/or SIC codes in which the stock is found.
Options Overview

Highlights important summary options statistics to provide a forward looking indication of investors' sentiment.

  • Implied Volatility: The average implied volatility (IV) of the nearest monthly options contract. IV is a forward looking prediction of the likelihood of price change of the underlying asset, with a higher IV signifying that the market expects significant price movement, and a lower IV signifying the market expects the underlying asset price to remain within the current trading range.

  • 20-Day Historical Volatility: The average deviation from the average price over the last 20 days. Historical Volatility is a measurement of how fast the underlying security has been changing in price back in time.

  • IV Percentile: The percentage of days with IV closing below the current IV value over the prior 1-year. A high IV Percentile means the current IV is at a higher level than for most of the past year. This would occur after a period of significant price movement, and a high IV Percentile can often predict a coming market reversal in price.

  • IV Rank: The current IV compared to the highest and lowest values over the past 1-year. If IV Rank is 100% this means the IV is at its highest level over the past 1-year, and can signify the market is overbought.

  • IV High: The highest IV reading over the past 1-year and date it happened.

  • IV Low: The lowest IV reading over the past 1-year and date it happened.

  • Put/Call Vol Ratio: The total Put/Call volume ratio for all option contracts (across all expiration dates). A high put/call ratio can signify the market is oversold as more traders are buying puts rather than calls, and a low put/call ratio can signify the market is overbought as more traders are buying calls rather than puts.

  • Today's Volume: The total volume for all option contracts (across all expiration dates) traded during the current session.

  • Volume Avg (30-Day): The average volume for all option contracts (across all expiration dates) for the last 30-days.

  • Put/Call OI Ratio: The put/call open interest ratio for all options contracts (across all expiration dates).

  • Today's Open Interest: The total open interest for all option contracts (across all expiration dates).

  • Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days.
Related Stocks

For comparison purposes, find information on other symbols contained in the same sector.

Most Recent Stories

View the latest top stories from the Associated Press or Canadian Press (based on your Market selection).

Sours: https://www.barchart.com

You will also like:

DexCom Inc (DXCM)

IHI iShares US Medical Devices ETF 3.51% WMGBX Delaware Ivy Mid Cap Growth B 3.48% FSMEX Fidelity® Select Medical Tech and Devcs 3.14% JDCRX Janus Henderson Forty R 2.35% RPG Invesco S&P 500® Pure Growth ETF 1.95% PCRSX Principal LargeCap Growth I R1 1.58% VMGIX Vanguard Mid-Cap Growth Index Investor 1.36% VOT Vanguard Mid-Cap Growth ETF 1.36% IWP iShares Russell Mid-Cap Growth ETF 1.27% VIMSX Vanguard Mid Cap Index Investor 0.72% VO Vanguard Mid-Cap ETF 0.72% IWR iShares Russell Mid-Cap ETF 0.46%
Sours: https://ycharts.com/companies/DXCM


293 294 295 296 297